The Mesoridazine Besylate Injection, cataloged under National Stock Number 6505-01-146-4205, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Boehringer Ingelheim Pharmaceuticals Inc. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 3 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-146-4205 |
| Primary Part Number | NDC00597-0027-10 |
| Item Name | Mesoridazine Besylate Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals Inc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Total Primary Container Quantity | 100 |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS MESORIDAZINE PER MILLILITER |
| Primary Container Content Quantity | 1.000 MILLILITERS |
| Primary Container Type | AMPUL |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00597-0027-10 PRIMARY | Boehringer Ingelheim Pharmaceuticals Inc (USA) |
| SERENTIL | Boehringer Ingelheim Pharmaceuticals Inc (USA) |
NSN 6505-01-146-4205 is a Mesoridazine Besylate Injection, manufactured by Boehringer Ingelheim Pharmaceuticals Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-146-4205 has 2 cross-referenced part numbers: NDC00597-0027-10 (Boehringer Ingelheim Pharmaceuticals Inc), SERENTIL (Boehringer Ingelheim Pharmaceuticals Inc).
There are 3 known substitutes for 6505-01-146-4205: 6505-00-137-7745, 6505-00-137-7746, 6505-00-159-8115. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00597-0027-10: Administration: INTRAMUSCULAR; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: MESORIDAZINE AS THE BESYLATE; Total Primary Container Quantity: 100. 7 total characteristics are documented in the Federal Logistics Information System.